Drug Development Revolution
The potential for AI to generate a multitude of new drug candidates is promising, yet the pharmaceutical industry must adapt its approach to enhance productivity. Rapid management changes and a focus on established relationships hinder progress, suggesting a need for a more merit-based partnering strategy. By leveraging AI to identify effective collaborations, the industry could significantly accelerate drug development, despite the inevitable challenges and failures along the way.In this clip
From this podcast
Eye on AI
Can Artificial Intelligence Extend Lifespan? | Alex Zhavoronkov
Related Questions